Phase 1 onCARlytics solid tumour trial advances to combination arm treatment
March 11, 2024 11:39 ET
|
Imugene Limited
Phase 1 trial of CD19 oncolytic virotherapy drug candidate onCARlytics cleared its first cohort within the intratumoral monotherapy arm of the study.